Assoc. Prof. Antonia Kisheva was born in 1974. in the city of Varna. In 1993 she completed her secondary education at the First Language High School - Varna, with the study of German language. In 1999 she graduated in medicine from the Medical University of Varna. As a trainee doctor in 1999 she conducts a 3-month internship in Internal Medicine in the city of Brussels, Belgium. Since 2001 to 04.04.2008 she works in her own practice as a general practitioner in the city of Varna. In 2007 acquired a specialty in General Medicine. From 04.2008. started working at the First Clinic of Cardiology. She acquired the specialty "Cardiology" in 12.2013. From 03.2014. is an assistant professor of cardiology at the Department of Internal Medicine. In 2017 she defended his dissertation on "The role of fibrosis and blocking of mineralocorticoid receptors in atrial fibrillation". From 06.06.2018. is a Chief Assistant Professor at the First Department of Computer Science. In 2021 she acquired the academic position of Associate Professor. The scientific areas in which she works are atrial fibrillation, arterial hypertension, ultrasound diagnostics, cardiology consultation of patients with stroke and heart failure. Dr. Kisheva has specialized and holds certificates in Echocardiography – fundamental and expert level, respectively, since 2014 and 2017. In 2013 conducted training in echocardiography and transcranial Doppler sonography in Messina, Italy.
Ass. Prof. Kisheva is a scientific secretary of the Society of Cardiology in Bulgaria, a member of the Bulgarian League of Hypertension, the Association of Echocardiography Specialists - Varna-Echo, the European Society of Cardiology, the European Council of stroke, the European Society of Hypertension. She is Chairman of the Board of Directors of the Heart-Lung Association and is Executive Secretary of the Heart-Lung Journal. Assoc. Prof. Kisheva has numerous participations with presentations and posters in international and national congresses, conferences and symposia.She has participated in a number of international multicenter clinical trials. She is the head of one national project.
